Pseudoprogression After Cemiplimab in Ocular Surface Squamous Neoplasia
This case report shows pseudoprogression with a subsequent good response to neoadjuvant anti–PD-1 therapy in ocular surface squamous neoplasia.
Authors
- Sara-Maude Desforges (ORCID: https://orcid.org/0009-0004-1981-2946)
- Antoine Desîlets (ORCID: https://orcid.org/0000-0002-9382-7597)
- Erika Massicotte
- Alexandre Nakao Odashiro
- Alexandre Pellan Cheng (ORCID: https://orcid.org/0000-0002-3667-0992)
- Minh Tri Le
- Kanchan Ramesh Sainani
Institutions
- Centre Hospitalier de l’Université de Montréal (CA)
- École de Technologie Supérieure (CA)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2026-10-08
- DOI
- https://doi.org/10.1001/jamaophthalmol.2026.4254
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00